Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study Says Bird-Flu Vaccine Comparison Tests Vary Too Much

This article was originally published in PharmAsia News

Executive Summary

A British study warns drug makers the tests they conduct to determine the effectiveness of their avian influenza vaccines may not be as true as previously thought. The study looked at the tests vaccine makers use and said the sensitivity of the tests varies according to values used. That, researchers said, could lead the pharmas to over- or under-estimate the effectiveness of their vaccine's smallest dose for protection when compared with a competitor. One expert said the study means an effort should be made to develop a consensus on the values to be measured in such tests. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel